66409-97-0

Basic information

• Product Name: (13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one
• Synonyms: (13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one;N-Butyl-12β,13α-dihydrojervine 3-acetate
• CAS NO: 66409-97-0
• Molecular Formula: C33H49NO4
• Molecular Weight: 523.83
• Mol File: 66409-97-0.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 605.82°C (rough estimate)
• Flash Point: 322.2°C
• Appearance: /
• Density: 1.0596 (rough estimate)
• Vapor Pressure: 8.88E-15mmHg at 25°C
• Refractive Index: 1.5960 (estimate)
• CAS DataBase Reference: (13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one(CAS DataBase Reference)
• NIST Chemistry Reference: (13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one(66409-97-0)
• EPA Substance Registry System: (13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one(66409-97-0)

Safety Data

• Hazardous Substances Data: 66409-97-0(Hazardous Substances Data)

Usage

Description

(13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one is a complex organic compound derived from veratramine, a toxic alkaloid present in Liliaceae family plants. This derivative features a butyl group, an epoxy ring, and an acetyloxy group, which contribute to its unique properties and reactivity. It has been investigated for its potential pharmacological properties, such as anti-cancer and anti-inflammatory activities.

Uses

Used in Pharmaceutical Industry:
(13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one is used as a pharmaceutical agent for its potential anti-cancer properties. It is being studied for its ability to target and inhibit the growth of cancer cells, offering a novel therapeutic approach in oncology.
Used in Research Applications:
In the field of scientific research, (13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one serves as a valuable compound for investigating the mechanisms of action behind its anti-cancer and anti-inflammatory effects. This research can lead to a better understanding of its potential applications and the development of new drugs based on its structure.
Used in Drug Development:
(13R)-3β-(Acetyloxy)-28-butyl-17,23β-epoxy-12β,13α-dihydroveratraman-11-one is utilized in drug development processes to create new pharmaceuticals with improved efficacy and reduced side effects. Its unique structural features make it a promising candidate for the design of innovative therapeutic agents.

InChI:InChI=1/C33H51NO4/c1-7-8-15-34-18-19(2)16-27-30(34)21(4)33(38-27)14-12-25-26-10-9-23-17-24(37-22(5)35)11-13-32(23,6)29(26)31(36)28(25)20(33)3/h9,19-21,24-30H,7-8,10-18H2,1-6H3/t19-,20+,21+,24-,25-,26-,27+,28+,29+,30-,32-,33?/m0/s1

Relevant articles and documents

Structure-activity relation of steroid teratogens. 3. Solanidan epimers.

-